Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus

European Journal of Pharmacology

Volumn 513, Issue 1-2, 2005, Pages 75-80

  Robotka, Hermina ^a   Németh, Hajnalka ^a   Somlai, Csaba ^a   Vécsei, László ^a   Toldi, József ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

(Rat); Glucosamine kynurenic acid; Hippocampus; Kynurenic acid; Neuroprotection; Probenecid

Indexed keywords

GLUCOSAMINE; KYNURENIC ACID; PROBENECID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EVOKED CORTICAL RESPONSE; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUDDEN DEATH;

ACTION POTENTIALS; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; GLUCOSAMINE; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; KYNURENIC ACID; MALE; PILOT PROJECTS; PROBENECID; PYRAMIDAL CELLS; RATS; RATS, WISTAR; URICOSURIC AGENTS;

EID: 18844388707     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.02.043     Document Type: Article

References (19)

1. G. Battaglia, M. La Russa, V. Bruno, L. Arenare, R. Ippolito, A. Copani, F. Bonina, and F. Nicoletti Systemically administered d-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents Brain Res. 860 2000 149 156
2. R. Carpenedo, A. Pittaluga, A. Cozzi, S. Attucci, A. Galli, M. Raiteri, and F. Moroni Presynaptic kynurenate-sensitive receptors inhibit glutamate release Eur. J. Neurosci. 13 2001 2141 2147
3. D.W. Choi Glutamate neurotoxicity and diseases of the nervous system Neuron 1 1988 623 634
4. S. Fukui, R. Schwarcz, S.I. Rapoport, Y. Takada, and Q.R. Smith Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism J. Neurochem. 56 1991 2007 2017
5. J. Füvesi, C. Somlai, H. Németh, H. Varga, Z. Kis, T. Farkas, N. Károly, M. Dobszay, Z. Penke, B. Penke, L. Vécsei, and J. Toldi Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid Pharmacol. Biochem. Behav. 77 2004 95 102
6. C. Hilmas, E.F. Pereira, M. Alkondon, A. Rassoulpour, R. Schwarcz, and E.X. Albuquerque The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications J. Neurosci. 21 2001 7463 7473
7. M. Kessler, T. Terramani, G. Lynch, and M. Baudry A glycine site associated with N-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists J. Neurochem. 52 1989 1319 1328
8. C. Kiss, F. Bari, J. Toldi, and L. Vécsei Kynurenine in the Brain: Therapeutic Perspectives 2004 Medicina Budapest 77 112
9. P. Klivényi, J. Toldi, and L. Vécsei Kynurenines in neurodegenerative disorders: therapeutic consideration Adv. Exp. Med. Biol. 541 2004 169 183
10. L.J. Martin, C.D. Blackstone, A.I. Levey, R.L. Huganir, and D.L. Price AMPA glutamate receptor subunits are differentially distributed in rat brain Neuroscience 53 1993 327 358
11. H. Monyer, N. Burnashev, D.J. Laurie, B. Sakmann, and P.H. Seeburg Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 1994 529 540
12. H. Németh, H. Robotka, Z. Kis, É. Rózsa, T. Janáky, C. Somlai, M. Marosi, T. Farkas, J. Toldi, and L. Vécsei Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study Neuropharmacology 47 2004 916 925
13. H.E. Scharfman, and J.H. Goodman Effects of central and peripheral administration of kynurenic acid on hippocampal evoked responses in vivo and in vitro Neuroscience 86 1998 751 764
14. R. Schwarcz, and R. Pellicciari Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities J. Pharmacol. Exp. Ther. 303 2002 1 10
15. T.W. Stone Neuropharmacology of quinolinic and kynurenic acids Pharmacol. Rev. 45 1993 309 379
16. T.W. Stone Kynurenic acid antagonists and kynurenine pathway inhibitors Expert Opin. Investig. Drugs 10 2001 633 645
17. T.W. Stone, G.M. Mackay, C.M. Forrest, C.J. Clark, and L.G. Darlington Tryptophan metabolites and brain disorders Clin. Chem. Lab. Med. 41 2003 852 859
18. L. Vécsei, J. Miller, U. MacGarvey, and M.F. Beal Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain Brain Res. Bull. 28 1992 233 238
19. M. Watanabe, Y. Inoue, K. Sakimura, and M. Mishina Distinct distributions of five N-methyl-d-aspartate receptor channel subunit mRNAs in the forebrain J. Comp. Neurol. 338 1993 377 390